Nhampossa, Tacilta
González, Raquel
Nhacolo, Arsenio
Garcia-Otero, Laura
Quintó, Llorenç
Mazuze, Maura
Mendes, Anete
Casellas, Aina
Bambo, Gizela
Couto, Aleny
Sevene, Esperança
Munguambe, Khátia
Menendez, Clara
Funding for this research was provided by:
career development fellowship co-funded by the EDCTP (European and Developing Countries Clinical Trials Partnership) and the Calouste Gulbenkian Foundation . (TMA2017CDF-1927 – Preg_multidrug)
Article History
Received: 23 June 2022
Accepted: 30 September 2022
First Online: 8 October 2022
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki and the National Bioethics Committee of Mozambique approved the study protocol in 2011 (327/CNBS/11), with subsequent annual renewals until the year 2020. After informing the pregnant women about the study objectives and methods, women consented for their participation, and that of their children, by signing a written informed consent. One copy of the consent form was handled to the participant.
: Not applicable.
: The authors declare no competing interests.